Sidse Ehmsen (S Ehmsen)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 8

Top Venues

Nature communications

Acta oncologica (Stockholm, Sweden)

Stem cells (Dayton, Ohio)

International journal of cancer

University of Southern Denmark

University of Southern Denmark (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Southern Denmark

Denmark

post. doc :: Cancer and inflammation research

Education History

University of Southern Denmark

Denmark

PHD :: Cancer and inflammation research

Publications

Shijun Ma, Yue Zhao, Wee Chyan Lee, Li-Teng Ong, Puay Leng Lee, Zemin Jiang, Gokce Oguz, Zhitong Niu, Min Liu, Jian Yuan Goh, Wenyu Wang, Matias A Bustos, Sidse Ehmsen, Adaikalavan Ramasamy, Dave S B Hoon, Henrik Jørn Ditzel, Ern Yu Tan, Qingfeng Chen, Qiang Yu
Hypoxia induces HIF1α-dependent epigenetic vulnerability in triple negative breast cancer to confer immune effector dysfunction and resistance to anti-PD-1 immunotherapy. Nature communications 13 (1) (2022)
Carla L Alves, Sidse Ehmsen, Mikkel G Terp, Neil Portman, Martina Tuttolomondo, Odd L Gammelgaard, Monique F Hundebøl, Kamila Kaminska, Lene E Johansen, Martin Bak, Gabriella Honeth, Ana Bosch, Elgene Lim, Henrik Jørn Ditzel
Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer. Nature communications 12 (1) (2021)
Sidse Ehmsen, L H Jakobsen, M E Lendorf, R L Eefsen, L Bentsen, A S Knoop, Ninna Aggerholm-Pedersen, H Skuladottir, J Herrstedt, L H Jensen, C Rotbøl, M B Damm, K Wedervang, Andreas Glenthoej, Jesper Ryg, Henrik Frederiksen, Annette Raskov Kodahl
Severity and 1-month outcome of SARS-CoV-2 infection in patients with solid cancers: a Danish nationwide cohort study. Acta oncologica (Stockholm, Sweden) 60 (7) (2021)
Carla L Alves, Sidse Ehmsen, Mikkel G Terp, Neil Portman, Martina Tuttolomondo, Odd L Gammelgaard, Monique F Hundebøl, Kamila Kaminska, Lene E Johansen, Martin Bak, Gabriella Honeth, Ana Bosch, Elgene Lim, Henrik Jørn Ditzel
Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer. Nature communications 12 (1) (2021)
Yi Bao, Gokce Oguz, Wee Chyan Lee, Puay Leng Lee, Kakaly Ghosh, Jiayao Li, Panpan Wang, Peter E Lobie, Sidse Ehmsen, Henrik Jørn Ditzel, Andrea Wong, Ern Yu Tan, Soo Chin Lee, Qiang Yu
EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy. Nature communications 11 (1) (2020)
Sidse Ehmsen, Henrik Jørn Ditzel
Signaling pathways essential for triple-negative breast cancer stem-like cells. Stem cells (Dayton, Ohio) 39 (2) (2020)
Martin H Pedersen, Brian L Hood, Sidse Ehmsen, Hans Christian Beck, Thomas P Conrads, Martin Bak, Henrik Jørn Ditzel, Rikke Leth-Larsen
CYPOR is a novel and independent prognostic biomarker of recurrence-free survival in triple-negative breast cancer patients. International journal of cancer 144 (3) (2018)
Annette R Kodahl, Sidse Ehmsen, Niels Pallisgaard, Anne M B Jylling, Jeanette D Jensen, Anne-Vibeke Laenkholm, Ann S Knoop, Henrik Jørn Ditzel
Correlation between circulating cell-free PIK3CA tumor DNA levels and treatment response in patients with PIK3CA-mutated metastatic breast cancer. Molecular oncology 12 (6) (2018)

Sidse Ehmsen.css-eqlu8i{font-size:small;padding-left:4px;} (S Ehmsen)

Publication Activity (10 Years)

Top Topics

Top Venues

Sidse Ehmsen (S Ehmsen)